Replies to post #1136 on Biotech Values

[DewDiligence]

tennis: I’ve never been a big fan of gene therapy, but TGEN strikes me as the cream of the crop. Given today’s news, I might take a closer look.

--
In (#msg-1981262), I placed a value of only $5M on GENR’s Lomucin program in CF. I’m now inclined to revise that valuation downward to zero.